Alberta occasionally approves coverage through special authorization, but approval rates sit below 15%
We spoke with stakeholders across the value chain, including clinicians, hospital and retail pharmacy contacts, payers, and distribution side experts, with coverage balanced across major European markets and the rest of the region
Different approaches and processing variations, such as donor selection and testing, fecal microbiome transplantation via the upper gastrointestinal tract, enema, or colonoscopy, as well as short- and long-term patient monitoring for adverse effects and treatment efficacy, introduce new challenges to be investigated
Thyroid cancer and insulin resistance
As research expands into multi-hormone pathways, the need for consistent, well-characterized, high-quality peptides becomes increasingly crucial for reliable, accurate experimental outcomes